First Tracks Biotherapeutics (TRAX) Stock: Why It's Up Today
Updated Oct 19, 2026, 4:00 PM ET · closing price
- Closed at $36.28, +5.28% vs the prior close of $34.46.
- Volume 1.43M shares, 1.7x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
TRAX jumps 5.3% to $36.28. Closed at $36.28, +5.28% vs the prior close of $34.46. Day range $35.00–$37.23, opened at $35.00.
TRAX daily analysis — what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 19, 2026 — TRAX jumps 5.3% to $36.28
- Closed at $36.28, +5.28% vs the prior close of $34.46. Day range $35.00–$37.23, opened at $35.00.
- Volume was 1.43M shares, 1.7x its 50-day average of 859.52K.
- Price is -7.1% vs its 50-day average ($39.07).
- 52-week range $14.72–$49.91; today's close sits at 61% of that range, 27.3% below the 52-week high.
Oct 16, 2026 — TRAX slides 4.4% to $34.46
- Closed at $34.46, -4.38% vs the prior close of $36.04. Day range $33.38–$37.07, opened at $37.07.
- Volume was 1.04M shares, 1.2x its 50-day average of 847.57K.
- Price is -12.2% vs its 50-day average ($39.25).
- 52-week range $14.72–$49.91; today's close sits at 56% of that range, 31.0% below the 52-week high.
Oct 15, 2026 — TRAX jumps 5.6% to $36.04 on 1.9x normal volume
- Closed at $36.04, +5.60% vs the prior close of $34.13. Day range $33.99–$36.30, opened at $34.69.
- Volume was 1.58M shares, 1.9x its 50-day average of 834.80K — unusually heavy trading.
- Price is -8.7% vs its 50-day average ($39.47).
- 52-week range $14.72–$49.91; today's close sits at 61% of that range, 27.8% below the 52-week high.
- SEC filings that day: 8-K.
Oct 14, 2026 — TRAX jumps 7.7% to $34.13
- Closed at $34.13, +7.73% vs the prior close of $31.68. Day range $30.88–$34.32, opened at $31.28.
- Volume was 982.10K shares, 1.2x its 50-day average of 828.95K.
- Price is -14.0% vs its 50-day average ($39.69).
- 52-week range $14.72–$49.91; today's close sits at 55% of that range, 31.6% below the 52-week high.
Oct 13, 2026 — TRAX slides 7.0% to $31.68
- Closed at $31.68, -6.96% vs the prior close of $34.05. Day range $31.12–$34.36, opened at $33.72.
- Volume was 1.11M shares, 1.4x its 50-day average of 811.90K.
- Price is -20.7% vs its 50-day average ($39.93).
- 52-week range $14.72–$49.91; today's close sits at 48% of that range, 36.5% below the 52-week high.
- SEC filings that day: 8-K.
Oct 12, 2026 — TRAX jumps 6.9% to $34.05 on 10.7x normal volume
- Closed at $34.05, +6.91% vs the prior close of $31.85. Day range $33.02–$40.50, opened at $39.45.
- Volume was 7.31M shares, 10.7x its 50-day average of 683.09K — unusually heavy trading.
- Price is -15.3% vs its 50-day average ($40.22).
- 52-week range $14.72–$49.91; today's close sits at 55% of that range, 31.8% below the 52-week high.
Oct 9, 2026 — TRAX dips 0.5% to $31.85
- Closed at $31.85, -0.50% vs the prior close of $32.01. Day range $30.71–$33.28, opened at $31.96.
- Volume was 855.20K shares, 1.2x its 50-day average of 685.39K.
- Price is -21.2% vs its 50-day average ($40.42).
- 52-week range $14.72–$49.91; today's close sits at 49% of that range, 36.2% below the 52-week high.
Oct 8, 2026 — TRAX jumps 4.6% to $32.01 on 2.2x normal volume
- Closed at $32.01, +4.64% vs the prior close of $30.59. Day range $30.11–$33.31, opened at $33.31.
- Volume was 1.48M shares, 2.2x its 50-day average of 667.36K — unusually heavy trading.
- Price is -21.4% vs its 50-day average ($40.73).
- 52-week range $14.72–$49.91; today's close sits at 49% of that range, 35.9% below the 52-week high.
Oct 7, 2026 — TRAX dips 2.5% to $30.59, a 3-month low, 7 down days in a row
- Closed at $30.59, -2.55% vs the prior close of $31.39. Day range $30.53–$31.75, opened at $30.91.
- Volume was 355.50K shares, 0.5x its 50-day average of 675.47K — lighter than usual.
- Price is -25.3% vs its 50-day average ($40.93).
- 52-week range $14.72–$49.91; today's close sits at 45% of that range, 38.7% below the 52-week high.
- That makes 7 straight losses.
Oct 6, 2026 — TRAX slides 4.8% to $31.39, a 1-month low, 6 down days in a row
- Closed at $31.39, -4.85% vs the prior close of $32.99. Day range $30.96–$33.02, opened at $33.02.
- Volume was 613.80K shares, 0.9x its 50-day average of 715.04K.
- Price is -23.7% vs its 50-day average ($41.16).
- 52-week range $14.72–$49.91; today's close sits at 47% of that range, 37.1% below the 52-week high.
- That makes 6 straight losses.
Oct 5, 2026 — TRAX dips 0.9% to $32.99, a 1-month low, 5 down days in a row
- Closed at $32.99, -0.87% vs the prior close of $33.28. Day range $30.88–$34.44, opened at $34.44.
- Volume was 667.80K shares, 0.9x its 50-day average of 711.59K.
- Price is -20.3% vs its 50-day average ($41.37).
- 52-week range $14.72–$49.91; today's close sits at 52% of that range, 33.9% below the 52-week high.
- That makes 5 straight losses.
Oct 2, 2026 — TRAX dips 1.9% to $33.28, a 1-month low, 4 down days in a row
- Closed at $33.28, -1.89% vs the prior close of $33.92. Day range $32.50–$35.41, opened at $34.45.
- Volume was 1.17M shares, 1.7x its 50-day average of 696.23K.
- Price is -19.7% vs its 50-day average ($41.42).
- 52-week range $14.72–$49.91; today's close sits at 53% of that range, 33.3% below the 52-week high.
- That makes 4 straight losses.
TRAX bull case vs bear case (from the data)
- No clear positive signal in the price trend, filings or insider data right now.
- Price is -7.1% vs its 50-day average — short-term trend is down.
- Insider selling outweighs buying: 8 sales vs 0 open-market buys among the 8 most recent reported insider trades (Form 4, last 12 months).
- High volatility: average daily move of 4.4% over 20 sessions.
TRAX latest news & SEC filings
Every SEC filing by or about TRAX in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 15, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 3.02 — Sold unregistered shares.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Oct 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Sep 17, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Orwin John A converted options/RSUs into 1,300 shares on Sep 15, 2026; now holds 17,995
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 4, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Ware J. Anthony sold 39,265 shares at $44.78 (≈$1.76M) on Sep 2, 2026
- Ware J. Anthony sold 39,265 shares at $44.78 (≈$1.76M) on Sep 2, 2026
- Ware J. Anthony sold 39,265 shares at $44.78 (≈$1.76M) on Sep 2, 2026
- Ware J. Anthony sold 39,265 shares at $44.78 (≈$1.76M) on Sep 2, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 2, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 18, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 18, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 18, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 14, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 12, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$33.37M (prior year -$42.45M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.95 (prior year -$1.47) (loss narrowed vs Jun 30, 2025)
Aug 12, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Things to know before you trade TRAX
- Last results release: Aug 12, 2026 (8-K Item 2.02). Previous ones: May 14, 2026. Based on that rhythm, the next report is likely around Nov 11, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 4.42% (largest 10.7%). That is a volatile stock.
- Liquidity: about 1.21M shares (≈$43.80M) trade per day on average.
- 52-week position: $36.28 vs a range of $14.72–$49.91 (61% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 8 sales; latest: J. Anthony Ware sold 39,265 shares on Sep 2, 2026.
- Latest filings: 8-K Oct 15, 2026; 8-K Oct 13, 2026; 10-Q Aug 12, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
TRAX market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 19, 2026 | 35.00 | 37.23 | 35.00 | 36.28 | 1.43M |
| Oct 16, 2026 | 37.07 | 37.24 | 33.38 | 34.46 | 1.04M |
| Oct 15, 2026 | 34.69 | 36.30 | 33.99 | 36.04 | 1.58M |
| Oct 14, 2026 | 31.28 | 34.32 | 30.88 | 34.13 | 982.10K |
| Oct 13, 2026 | 33.72 | 34.36 | 31.12 | 31.68 | 1.11M |
| Oct 12, 2026 | 39.45 | 40.50 | 33.02 | 34.05 | 7.31M |
| Oct 9, 2026 | 31.96 | 33.28 | 30.71 | 31.85 | 855.20K |
| Oct 8, 2026 | 33.31 | 33.31 | 30.11 | 32.01 | 1.48M |
| Oct 7, 2026 | 30.91 | 31.75 | 30.53 | 30.59 | 355.50K |
| Oct 6, 2026 | 33.02 | 33.02 | 30.96 | 31.39 | 613.80K |
| Oct 5, 2026 | 34.44 | 34.44 | 30.88 | 32.99 | 667.80K |
| Oct 2, 2026 | 34.45 | 35.41 | 32.50 | 33.28 | 1.17M |
| Oct 1, 2026 | 35.20 | 36.03 | 33.77 | 33.92 | 564.10K |
| Sep 30, 2026 | 36.74 | 37.31 | 35.32 | 35.44 | 610.60K |
| Sep 29, 2026 | 36.61 | 36.80 | 34.99 | 35.98 | 645.50K |
| Sep 28, 2026 | 34.40 | 37.24 | 33.55 | 36.65 | 674.50K |
| Sep 25, 2026 | 35.82 | 35.82 | 33.66 | 34.42 | 356.50K |
| Sep 24, 2026 | 36.11 | 37.09 | 34.57 | 35.83 | 1.14M |
| Sep 23, 2026 | 41.14 | 41.38 | 36.57 | 36.66 | 658.40K |
| Sep 22, 2026 | 39.43 | 42.24 | 39.37 | 41.03 | 893.20K |
About First Tracks Biotherapeutics
First Tracks Biotherapeutics (TRAX) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in SAN DIEGO, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 2091349.
TRAX board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Dennis M Fenton | Director | Jun 17, 2026 |
| Daniel Faga | President, CEO | Aug 18, 2026 |
| Rita Jain | Director | Jun 17, 2026 |
| Magda Marquet | Director | Jun 17, 2026 |
| John A Orwin | Director | Sep 17, 2026 |
| John P. Schmid | Director | Jun 17, 2026 |
| J. Anthony Ware | Director | Sep 4, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Daniel Faga | President, CEO | Aug 18, 2026 |
| Paul F. Lizzul | Chief Medical Officer | Aug 18, 2026 |
| Benjamin Stone | Chief Business Officer | Aug 18, 2026 |
| Ajim Tamboli | Chief Financial Officer | May 14, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 2, 2026 | J. Anthony Ware | Sale | 39,265 | $44.78 |
| Sep 2, 2026 | J. Anthony Ware | Sale | 39,265 | $44.78 |
| Sep 2, 2026 | J. Anthony Ware | Sale | 39,265 | $44.78 |
| Sep 2, 2026 | J. Anthony Ware | Sale | 39,265 | $44.78 |
| Apr 20, 2026 | Capital, Llc Ecor1 | Sale | 4,705,575 | $13.81 |
| Apr 20, 2026 | Capital, Llc Ecor1 | Sale | 4,705,575 | $13.81 |
| Apr 20, 2026 | Capital, Llc Ecor1 | Sale | 4,705,575 | $13.81 |
| Apr 20, 2026 | Capital, Llc Ecor1 | Sale | 4,705,575 | $13.81 |
TRAX financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $183.14M, total liabilities $—, cash $168.02M (as of Jun 30, 2026).
TRAX earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 12, 2026 | 8-K Item 2.02 (results) | $46.13 |
| May 14, 2026 | 8-K Item 2.02 (results) | $18.16 |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Regeneron Pharmaceuticals (REGN)Novo Nordisk A S (NVO)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)Tesla (TSLA)Space Exploration Technologies (SPCX)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on TRAX
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 19, 2026, 4:00 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.